NuOrtho's surgical probe cleared by FDA
This article was originally published in Clinica
Executive Summary
The US FDA has granted 510(k) clearance for NuOrtho Surgical's Ceruleau, an electrosurgical probe designed to remove damaged cartilage tissue. The device is intended for use during knee or shoulder surgery. It reduces damage to healthy cartilage, NuOrtho claims, because it operates at lower temperatures and energy levels than similar devices. This is the first approval for the firm, which is based at the Advanced Technology and Manufacturing Center of the University of Massachusetts, Dartmouth. The centre helps support start-up companies, and aims to promote partnerships between the university and industry.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.